SLNSW-Maintenance strategies after first-line oxaliplat...-TN_cdi_proquest_journals_1718114129

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Full title: Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Author/creator: Hegewisch-Becker, Susanna, Prof, Graeven, Ullrich, MD, Lerchenmüller, Christian A, MD, Killing, Birgitta, MD, Depenbusch, Reinhard, MD, Steffens, Claus-Christoph, MD, Al-Batran, Salah-Eddin, Prof, Lange, Thoralf, Prof, Dietrich, Georg, MD, Stoehlmacher, Jan, Prof, Tannapfel, Andrea, Prof, Reinacher-Schick, Anke, Prof, Quidde, Julia, MD, Trarbach, Tanja, MD, Hinke, Axel, PhD, Schmoll, Hans-Joachim, Prof, Arnold, Dirk, Prof.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1718114129

Language: English

Formats: Articles

Publishers: England: Elsevier B.V

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1718114129

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

    Record identifier

    TN_cdi_proquest_journals_1718114129

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1718114129

    Share

    Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1718114129

    Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

    Full title

    Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

    Author / Creator

    Hegewisch-Becker, Susanna, Prof ; Graeven, Ullrich, MD ; Lerchenmüller, Christian A, MD ; Killing, Birgitta, MD ; Depenbusch, Reinhard, MD ; Steffens, Claus-Christoph, MD ; Al-Batran, Salah-Eddin, Prof ; Lange, Thoralf, Prof ; Dietrich, Georg, MD ; Stoehlmacher, Jan, Prof ; Tannapfel, Andrea, Prof ; Reinacher-Schick, Anke, Prof ; Quidde, Julia, MD ; Trarbach, Tanja, MD ; Hinke, Axel, PhD ; Schmoll, Hans-Joachim, Prof ; Arnold, Dirk, Prof

    Publisher

    England: Elsevier B.V

    Journal title

    The lancet oncology, 2015, Vol.16 (13), p.1355-1369

    Record Identifier

    TN_cdi_proquest_journals_1718114129

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Aged Aged, 80 and over Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Antimitotic agents Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - adverse effects Bevacizumab - therapeutic use Cancer Cancer patients Cancer therapies Capecitabine - adverse effects Capecitabine - therapeutic use Care and treatment Chemotherapy Colorectal cancer Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Disease Progression Drug dosages Drug Substitution Female Fluorouracil - adverse effects Fluorouracil - therapeutic use Germany Heart attacks Hematology, Oncology and Palliative Medicine Humans Hypertension Intention to Treat Analysis Kaplan-Meier Estimate Leucovorin - adverse effects Leucovorin - therapeutic use Maintenance Chemotherapy Male Metastasis Middle Aged Neoplasm Metastasis Oncology Organoplatinum Compounds - adverse effects Organoplatinum Compounds - therapeutic use Ovarian cancer Product development Risk Factors Studies Time Factors Treatment Failure

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1718114129

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1718114129

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections